Rapid Nutrition PLC · EURONEXT:ALRPD
Rapid Nutrition — Investor Presentation (November 2026)
15 slides from Rapid Nutrition's investor presentation, Nov 4, 2026
Slide 1: Building a Global HealthTech Platform for Personalized Nutrition & Immune Science
Global HealthTech Building a Global HealthTech Platform for Personalized Nutrition & Immune Science From premium nutraceuticals to AI -enabled, clinically validated wellness systems 01 Investor Presentation | ALRPD | Euronext Growth
Slide 2: Strategic Vision & Direction
Strategic Vision & Direction This presentation outlines the Company ’s strategic vision and areas of focus as at the date of this presentation . It reflects management ’s current objectives, priorities, and initiatives, which may evolve or change in response to market conditions, regulatory consider
Slide 3: About The Company
About The Company Rapid Nutrition is dedicated to the research, development, and global distribution of premium health and wellness products grounded in scientific evidence . Its philosophy — “made by nature, refined by science ” — underscores a commitment to quality, transparency, and efficacy . Wi
Slide 4: Leadership Team
Leadership Team Meet the experts shaping our category and growth Simon St Ledger Michael Zhu Carl Seletz Ruth Kendon Dr. David Hunter CEO & Executive CFO, Member of the Advisory Member Head of Research and Scientific Advisory Board Director Institute of Chartered Product Development Member Accountan
Slide 5: Company Identity Transformation
Comp any Identity Transformation CURRENT BUSINESS PROFILE PLATFORM DIRECTION • Premium nutraceutical portfolio Precision wellness & immune science platform • Global distribution footprint AI-driven personalization engine • Patented antiviral formulation • Direct-to-consumer and wholesale Clinically
Slide 6: Expanding Portfolio of Science-Backed Wellness Brands
Expanding Portfolio of Science -Backed Wellness Brands Rapid Nutrition builds and operates a growing portfolio of evidence -based nutrition and wellness brands, encompassing both flagship and select third-party offerings, leveraging in- house innovation, natural science, and strategic partnerships t
Slide 7: Why Personalized & Preventive Wellness
Why Preventive Healthcare Shift High -Value Demographics Personalized Global transition from Attractive, h igh-value reactive treatment to consumer segments prevention & Preventive Perso nalization Da ta Drives Wellness Replacing Mass Supplements One -size -fits-all products Lifetime Value P ersonal
Slide 8: Rapid Nutrition at an Inflection Point
Rapid Nutrition at an Infl ection Point 1 Capital structure reset underway AI integration inside existing revenue engine 2 3 Clinical validation through US-based studies 4 Expansion across APAC, USA and Europe 5 Platform monetisation pathways opening 08 Investor Presentation | ALRPD | Euronext Growt
Slide 9: From Products to Platform: RapidX
From Products to “The wellness economy has Platform: RapidX consistently grown faster than global GDP, and is • Personalized wellness protocols projected to • Monthly AI -designed supplement systems approach nearly US • Integration of customer health data $9.8 trillion by 2029 .” • Real -world evide
Slide 10: Science, IP & Clinical Credibility
Science, IP & Clinical Credibility G ranted patents and Pa rticipation in large -scale Scie ntific advisory leadership Re gulatory -compliant proprietary formulations US clinical studies development standards AS SEEN: As part of this groundbreaking $17.1million international clinical trial, SystemLS
Slide 11: Multi-Engine Revenue Model
Multi -Engine Revenu e Model Diversified revenue streams designed to support scalable and resilient growth 1.P roduct sales (direct -to-consumer and wholesale) 2.Personalized subscriptions 3.Practitioner & clinic channels 4.Licensing & IP partnerships 11 Investor Presentation | ALRPD | Euronext Grow
Slide 12: Disciplined, Platform-Led Acquisitions
Dis ciplined, Platform -Led Acquisitions Revenue: High-margin, $2–10m profitable Platform leverage potential post- Category acquisition adjacency 12 Investor Presentation | ALRPD | Euronext Growth
Slide 13: Investment Highlights
Investment Highlights In health markets, scalable science drives long -term value . 13 Investor Presentation | ALRPD | Euronext Growth
Slide 14: Near-Term Execution Priorities
Near -Term Execution Priorities AI Activation Science & Validation Geographic Expansion • Personalized onboarding & • SystemLS clinical repositioning • APAC and North America scale protocols • Publication of existing study • Subscription-led DTC growth • AI-assisted pricing and summaries funnel opti
Slide 15: Discover the Next Wellness Revolution Opportunity
Discover the Next Wellness Revolution Opportunity Stay up to date with Rapid Nutrition ’s strategic priorities, portfolio evolution, and market developments. [email protected] www.rnplc.com +44 (0 ) 208 040 3498 15 Investor Presentation | ALRPD | Euronext Growth
Rapid Nutrition — Investor Presentation (November 2026) on 6ix